How to Treat Hypermagnesemia: A Step-by-Step Approach

Treatment of hypermagnesemia follows a severity-based ladder: discontinue every magnesium source, give intravenous calcium to stabilize the heart and nerves, push fluids and loop diuretics to help the kidneys flush the excess, and escalate to dialysis if kidney function is too poor to keep up. The condition is uncommon in people with healthy kidneys, but when it does develop, the progression from mild muscle weakness to cardiac arrest can be rapid enough that recognizing and treating it early genuinely changes outcomes.

Why Most Cases Trace Back to Two Overlapping Factors

Under normal circumstances, the kidneys are remarkably efficient at dumping extra magnesium into the urine. Healthy kidneys can ramp up magnesium excretion fast enough that even moderately excessive oral intake rarely pushes blood levels into dangerous territory. Trouble starts when one of two conditions is present, and especially when both are present at once: the kidneys are not working properly, or the person is taking in an unusually large amount of magnesium from an outside source.

Kidney dysfunction, whether acute or chronic, is the single most common backdrop for hypermagnesemia. When the kidneys can no longer filter and excrete efficiently, even standard magnesium intake can accumulate. But the combination of impaired kidneys and a magnesium-heavy intake is where most clinical cases land. Exogenous sources include magnesium-containing laxatives, antacids, cathartics, enemas, and oral supplements.¹ People with chronic constipation are a particularly vulnerable group: retained magnesium-based laxatives sitting in the gut act as a slow-release reservoir, continuously feeding magnesium into the bloodstream even after the last dose. One fatal case involved a woman with chronic obstructive pulmonary disease and chronic constipation who had been routinely using magnesium-containing laxatives, and the retained drug kept pushing magnesium levels higher.

Intravenous magnesium sulfate given in hospitals is another major route. It is used widely to treat preeclampsia, eclampsia, and certain cardiac arrhythmias. When doses are miscalculated or infusion rates are set incorrectly, magnesium toxicity can develop quickly, especially if the patient’s kidney function dips during treatment.² Prevention in high-risk groups, particularly anyone with impaired kidney function or anyone receiving magnesium-containing medications, is the most effective strategy.³

How Symptoms Escalate as Magnesium Rises

The clinical picture of hypermagnesemia is progressive and fairly predictable. At mildly elevated levels, symptoms can be subtle: nausea, flushing, and a general feeling of lethargy. As levels climb, the neuromuscular effects dominate. Magnesium acts as a calcium antagonist at the neuromuscular junction, which means excess magnesium effectively dampens nerve-to-muscle signaling. The earliest objective sign clinicians look for is the loss of deep tendon reflexes, particularly the patellar (knee-jerk) reflex. Checking this reflex is quick, costs nothing, and provides real-time information about whether magnesium is approaching toxic territory.

At higher levels, muscle weakness progresses to flaccid paralysis, the muscles of breathing can be affected, and respiratory failure becomes a real risk. One case report describes a patient whose magnesium level reached 9.2 mg/dL (normal is roughly 1.6 to 2.3 mg/dL) and who developed flaccid paralysis and respiratory failure requiring mechanical ventilation.⁴ Recovery of muscle function in that patient took two to three days even after magnesium levels were brought back down.

The cardiovascular system is also a target. Magnesium slows conduction through the heart, and severe hypermagnesemia can produce electrocardiogram changes that look strikingly like hyperkalemia: tall, peaked T waves, a widened QRS complex, and irregular conduction patterns. In at least one pediatric case involving a child on peritoneal dialysis, these ECG findings were initially misdiagnosed as hyperkalemia before the true culprit, elevated magnesium, was identified.⁵ At extremely high levels, complete heart block and cardiac arrest can occur. The overlap with hyperkalemia on ECG is an important diagnostic pitfall worth keeping in mind.

Step One: Stop Every Magnesium Source

Before any treatment is administered, the first and most critical step is identifying and immediately discontinuing all sources of magnesium. This sounds obvious, but in practice it is easy to miss. Patients may be receiving magnesium from multiple directions simultaneously: an IV drip in one arm, a magnesium-containing antacid on the medication list, and a bowel prep with a magnesium cathartic ordered by a different team. Hospital medication reconciliation often catches obvious duplications, but magnesium hides in many over-the-counter products that patients bring from home or that appear under unfamiliar brand names.

For outpatients, the same principle applies. If you or someone you know develops symptoms consistent with hypermagnesemia and takes magnesium supplements, magnesium-based laxatives like milk of magnesia, or antacids that contain magnesium hydroxide, stopping those products is the immediate first move while seeking medical evaluation. In cases where a magnesium-containing laxative or cathartic has been retained in the gut, there may be value in trying to evacuate the bowel to remove the ongoing absorption reservoir.

Calcium Gluconate as a Cardiac and Neuromuscular Shield

Intravenous calcium gluconate is the cornerstone of acute stabilization in symptomatic hypermagnesemia. Calcium directly antagonizes the effects of magnesium at the cell membrane. It does not lower the magnesium level itself; what it does is temporarily restore more normal neuromuscular and cardiac function while other measures work to actually clear the excess magnesium. Think of it as buying time rather than fixing the underlying problem.

Calcium gluconate is given intravenously, typically over several minutes, and the effect is rapid. It can reverse hypotension, improve cardiac conduction abnormalities, and counteract the neuromuscular depression that threatens breathing. In obstetric settings, where magnesium sulfate is used to prevent seizures in preeclampsia and eclampsia, calcium gluconate is always kept at the bedside as the designated rescue agent. Data aggregated across thousands of women treated with magnesium sulfate for preeclampsia show that calcium gluconate was actually administered in fewer than 0.2% of cases, suggesting that severe toxicity requiring rescue is uncommon when monitoring is in place.⁶

The calcium effect is temporary, though. It stabilizes the situation for minutes to perhaps an hour or two, not indefinitely. That window of stability is meant to allow time for the definitive treatment: getting the magnesium out of the body.

Clearing Magnesium With Fluids, Diuretics, and Renal Support

If the kidneys are still functioning, the next step is to help them work faster. Intravenous normal saline increases the volume of fluid flowing through the kidneys and dilutes the serum magnesium concentration. Loop diuretics such as furosemide can be added to further increase urinary magnesium excretion. The combination of aggressive hydration and diuresis is usually sufficient for mild to moderate hypermagnesemia in patients whose kidneys are in reasonable working order.

The key caveat is that this approach depends entirely on having kidneys that can respond. In a patient with acute kidney injury or advanced chronic kidney disease, IV fluids and diuretics accomplish little because the kidneys cannot filter the magnesium out no matter how much fluid you push through. Monitoring urine output closely during treatment tells you whether the kidneys are keeping up. If they are not, or if the magnesium level is dangerously high and the clinical picture is deteriorating, the threshold for dialysis should be low.

When Dialysis Becomes the Only Option

Hemodialysis is the most efficient way to remove magnesium from the blood, and it becomes essential when kidney function is absent or severely impaired. Standard dialysate used in hemodialysis contains a much lower magnesium concentration than the patient’s blood, so magnesium moves out across the dialysis membrane along its concentration gradient. The result can be dramatic.

In one reported case, a patient’s magnesium level climbed to 16.7 mg/dL, roughly seven times the upper limit of normal. He was treated initially with standard hemodialysis followed by continuous dialysis, and the combination brought the level down rapidly and resolved his muscular weakness.⁷ In another case involving a patient with acute oliguric kidney injury and a magnesium level of 9.2 mg/dL, intermittent hemodialysis was used until magnesium returned to normal. His paralysis gradually improved over the following 48 to 72 hours, and he was eventually weaned off the ventilator.⁴

Continuous forms of dialysis, such as continuous venovenous hemodialysis, may be preferred when the patient is hemodynamically unstable or when a slower, more controlled magnesium removal is desired. The choice between intermittent and continuous dialysis depends on the clinical scenario, and in severe cases, starting with intermittent hemodialysis for rapid correction and then switching to continuous therapy is a reasonable approach.

Supportive Care and Airway Management

While the steps above address the magnesium itself, severe hypermagnesemia often requires significant supportive care in parallel. The most dangerous immediate complication is respiratory failure from paralysis of the breathing muscles. Any patient with rapidly rising magnesium levels, progressive weakness, or diminished respiratory effort needs close monitoring in an intensive care setting with mechanical ventilation available.

Patients who develop respiratory failure from hypermagnesemia may need the ventilator for days, not hours. In the case described earlier with a magnesium level of 9.2 mg/dL, the patient required prolonged mechanical ventilation even after magnesium levels normalized, because the neuromuscular junction takes time to recover after being suppressed.⁴ Families and patients should understand that the recovery of muscle strength, including breathing strength, lags behind the correction of the blood magnesium level.

Hypermagnesemia in Pregnancy and the Newborn

Magnesium sulfate is one of the most commonly used drugs in obstetrics. It is the standard treatment for preventing and treating seizures in preeclampsia and eclampsia, and it is given at high doses. The risk of toxicity is built into the therapy, which is why bedside monitoring of reflexes, respiratory rate, and urine output is standard practice whenever magnesium sulfate is running. Across aggregated data from thousands of women, the rate of absent patellar reflexes during treatment was about 1.6%, and respiratory depression occurred in roughly 1.3%.⁶

The danger increases substantially when preeclampsia itself damages the kidneys, which it frequently does. A case report of a 22-year-old woman at 32 weeks of gestation illustrates this: she was treated with a standard magnesium sulfate regimen for eclampsia, but her renal function had deteriorated from the disease process. She developed magnesium toxicity severe enough to require emergency cesarean delivery under general anesthesia, followed by mechanical ventilation and hemodialysis in the ICU.⁸ The standard dosing regimen was not the problem; the kidneys’ inability to clear the drug was.

Newborns born to mothers who received magnesium sulfate also end up with elevated magnesium levels, because magnesium crosses the placenta freely. Neonatal magnesium concentrations correlate with maternal levels, though there is substantial individual variability in how high the baby’s levels go.⁹ The reassuring finding is that this neonatal hypermagnesemia typically resolves on its own within the first 48 hours of life, without causing lasting calcium disturbances.¹⁰ Neonates who appear lethargic or hypotonic after maternal magnesium exposure should have their levels checked, but invasive treatment is rarely necessary.

Electrolyte Disturbances That Tag Along

Hypermagnesemia does not exist in isolation. Elevated magnesium can drag other electrolytes out of their normal ranges, and overlooking these secondary derangements can complicate treatment. The two most common accompanying problems are low calcium and high potassium.

Magnesium suppresses parathyroid hormone secretion, which in turn leads to a drop in serum calcium. It also competes with calcium at cell membranes, magnifying the clinical effect of even a modest calcium decrease. In one documented case of a preeclamptic patient receiving magnesium infusion therapy, significant shifts in both calcium and potassium levels were observed that tracked directly with the rising and falling magnesium levels.¹¹ These electrolyte shifts are clinically relevant because low calcium amplifies the neuromuscular depression already caused by high magnesium, and high potassium adds its own cardiac risks to an already stressed heart.

The practical takeaway is that treating hypermagnesemia means checking and correcting calcium and potassium simultaneously. Giving IV calcium gluconate serves double duty here: it both antagonizes the magnesium and addresses the accompanying hypocalcemia. Potassium, on the other hand, may need separate management, and standard hyperkalemia interventions such as insulin with glucose, or sodium bicarbonate when there is acidosis, may be needed alongside the magnesium-focused therapy.

Preventing Hospital-Acquired Magnesium Toxicity

A meaningful fraction of hypermagnesemia cases are iatrogenic, meaning they are caused by the medical treatment itself. This is especially true for intravenous magnesium sulfate, where dosing, dilution, and infusion rate errors can push levels to dangerous heights quickly. A systematic review of intravenous magnesium administration errors found that the most common contributors were skill-based errors in preparation, adverse mental states of the healthcare workers involved, breakdowns in communication and care coordination, and deficiencies in processes specifically related to magnesium handling.¹²

Prevention strategies that hospitals use include standardized order sets with pre-calculated concentrations, mandatory pharmacist verification before magnesium infusions begin, smart infusion pumps that flag out-of-range rates, and hard stops requiring documented kidney function before magnesium is prescribed. For patients on ongoing magnesium therapy, serial magnesium levels and regular clinical assessments of reflexes and respiratory status are the monitoring baseline. One case of iatrogenic toxicity was traced to a simple preparation error during compounding of the infusion on the ward, reinforcing that even straightforward protocols can fail at the human-execution level.²

Why Hypermagnesemia Deserves More Attention Than It Gets

Hypermagnesemia is often treated as a footnote in electrolyte discussions, overshadowed by conditions like hyperkalemia and hypocalcemia that are more common and better studied. But the evidence suggests that when hypermagnesemia does occur, it is a meaningful marker of clinical danger. In one hospital-based study of 180 patients with poor clinical outcomes, about a third had hypermagnesemia, and the association between elevated magnesium and poor prognosis was statistically significant.¹³ Whether the elevated magnesium is a contributor to bad outcomes or mainly a reflection of severe underlying illness (like kidney failure or multiorgan dysfunction) remains debated, but either way, it should not be dismissed as a benign lab curiosity.

The body’s handling of magnesium is actually well designed to prevent toxicity. Intestinal absorption of magnesium involves both an active transport mechanism that has a built-in ceiling and a passive pathway that absorbs a small fixed fraction of ingested magnesium regardless of how much is consumed.¹⁴ The bioavailability of magnesium from food and supplements varies widely depending on the dose, the form of magnesium, and what else is in the meal.¹⁵ At normal oral intakes, this system keeps things in check. The system breaks down when magnesium is delivered intravenously (bypassing the gut entirely), when kidney clearance fails, or when large amounts of magnesium-containing products pool in the colon and create a reservoir for continuous absorption. Understanding where the body’s safety nets are and where they have gaps makes it far easier to anticipate which patients are heading for trouble before the lab value confirms it.